AAAAAA

   
Results: 1-1 |
Results: 1
The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway
Authors: Birkenkamp, KU Tuyt, LML Lummen, C Wierenga, LTJ Kruijer, W Vellenga, E
Citation: Ku. Birkenkamp et al., The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway, BR J PHARM, 131(1), 2000, pp. 99-107
Risultati: 1-1 |